{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:30Z","timestamp":1786979610412,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,3,21]],"date-time":"2003-03-21T00:00:00Z","timestamp":1048204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00105-003-0521-6","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T14:52:05Z","timestamp":1478011925000},"page":"413-417","source":"Crossref","is-referenced-by-count":48,"title":["Antipruritische Wirkung von Pimecrolimus und Tacrolimus"],"prefix":"10.1007","volume":"54","author":[{"given":"S.","family":"St\u00e4nder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,3,21]]},"reference":[{"key":"0521_CR1","doi-asserted-by":"crossref","unstructured":"Boguniewicz M, Fiedler VC, Raimer S et al. (1998) A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 102:637\u2013644","DOI":"10.1016\/S0091-6749(98)70281-7"},{"key":"0521_CR2","doi-asserted-by":"crossref","unstructured":"B\u00f6hm M, Frieling U, Luger TA, Bonsmann G (in press) Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol","DOI":"10.1001\/archderm.139.7.922"},{"key":"0521_CR3","unstructured":"Bornh\u00f6vd EC, Burgdorf WHC, Wollenberg A (2002) Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases. Curr Opin Invest Drugs 3:708\u2013712"},{"key":"0521_CR4","doi-asserted-by":"crossref","unstructured":"Breuer-McHam JN, Marshall GD, Lewis DE, Duvic M (1998) Distinct serum cytokines in AIDS-related skin diseases. Viral Immunol 11:215\u2013220","DOI":"10.1089\/vim.1998.11.215"},{"key":"0521_CR5","unstructured":"Cherill R, Tofte S, MacNaul R et al. (2000) SDZ ASM 981 1% cream is effective in the treatment oc chronic irritant hand dermatitis. J Eur Acad Dermatol Venereol 14 [Suppl 1]:128"},{"key":"0521_CR6","doi-asserted-by":"crossref","unstructured":"Choi CJ, Nghiem P (2001) Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Arch Dermatol 137:1202\u20131206","DOI":"10.1001\/archderm.137.9.1202"},{"key":"0521_CR7","doi-asserted-by":"crossref","unstructured":"DePaulis A, Stellato C, Cirillo R (1992) Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol 99:723\u2013728","DOI":"10.1111\/1523-1747.ep12614216"},{"key":"0521_CR8","doi-asserted-by":"crossref","unstructured":"Eichenfield LF, Lucky AW, Boguniewicz M et al. (2002) Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatits in children and adolescents. J Am Acad Dermatol 46:495\u2013504","DOI":"10.1067\/mjd.2002.122187"},{"key":"0521_CR9","doi-asserted-by":"crossref","unstructured":"Goldman D (2001) Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 44:995\u2013998","DOI":"10.1067\/mjd.2001.114739"},{"key":"0521_CR10","doi-asserted-by":"crossref","unstructured":"Hanifin JM, Ling MR, Langley R et al. (2001) Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol 44 [Suppl]:S28\u201338","DOI":"10.1067\/mjd.2001.109810"},{"key":"0521_CR11","doi-asserted-by":"crossref","unstructured":"Kang S, Lucky AW, Pariser D et al. (2001) Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 44 [Suppl]:S58\u201364","DOI":"10.1067\/mjd.2001.109812"},{"key":"0521_CR12","doi-asserted-by":"crossref","unstructured":"Kapp A, Papp K, Bingham A et al. (2002) Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allery Clin Immunol 110:277\u2013284","DOI":"10.1067\/mai.2002.126500"},{"key":"0521_CR13","doi-asserted-by":"crossref","unstructured":"Kato A, Takita T, Furuhashi M et al. (2001) Polymethylmethacrylate efficay in reduction of renal itching in hemodialysis patients: crossover study and role of tumor necosis factor-\u03b1. Artificial Organs 25:441\u2013447","DOI":"10.1046\/j.1525-1594.2001.025006441.x"},{"key":"0521_CR14","doi-asserted-by":"crossref","unstructured":"Luger T, van Leent EJM, Graeber M et al. (2001) SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 144:788\u2013794","DOI":"10.1046\/j.1365-2133.2001.04134.x"},{"key":"0521_CR15","doi-asserted-by":"crossref","unstructured":"Mayer K, Reinhard T, Reis A et al. (2001) FK 506 ointment 0.1% - a new therapeutic option for atopic blepharitis. Clinical trial with 14 patients. Klin Monatsbl Augenheilkd 218:733\u2013736","DOI":"10.1055\/s-2001-18665"},{"key":"0521_CR16","doi-asserted-by":"crossref","unstructured":"Meurer M, F\u00f6lster-Holst R, Wozel G et al. (2002) Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology 205:271\u2013277","DOI":"10.1159\/000065863"},{"key":"0521_CR17","doi-asserted-by":"crossref","unstructured":"Nakagawa H, Etoh T, Ishibashi Y et al. (1994) Tacrolimus ointment for atopic dermatitis. Lancet 344:883","DOI":"10.1016\/S0140-6736(94)92855-X"},{"key":"0521_CR18","doi-asserted-by":"crossref","unstructured":"Neckermann G, Bavandi A, Meingassner JG (2000) Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981. Br J Dermatol 142:669\u2013679","DOI":"10.1046\/j.1365-2133.2000.03411.x"},{"key":"0521_CR19","doi-asserted-by":"crossref","unstructured":"Pauli-Magnus C, Klumpp S, Alscher DM et al. (2000) Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int 20:802\u2013803","DOI":"10.1177\/089686080002000641"},{"key":"0521_CR20","doi-asserted-by":"crossref","unstructured":"Reitamo S, Wollenberg A, Sch\u00f6pf E et al. (2000) Safety and efficacy of 1\u00a0year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 136:999\u20131006","DOI":"10.1001\/archderm.136.8.999"},{"key":"0521_CR21","doi-asserted-by":"crossref","unstructured":"Reitamo S, Van Leent EJM, Ho V et al. (2002) Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 109:539\u2013546","DOI":"10.1067\/mai.2002.121831"},{"key":"0521_CR22","unstructured":"St\u00e4nder S, Steinhoff M, St\u00e4nder H, Luger TA (in press) Morphological evidence of neuropeptide release and mast cell degranulation in tacrolimus (FK 506) and pimecrolimus (SDZ ASM 981) treated murine skin. J Invest Dermatol (Abstr)"},{"key":"0521_CR23","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S, Weisshaar E, Steinhoff M et al. (2003) Pruritus\u2014Pathophysiologie, Klinik und Therapie. Eine \u00dcbersicht. JDDG 1:105\u2013118","DOI":"10.1046\/j.1610-0387.2003.02023.x"},{"key":"0521_CR24","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S, Steinhoff M (2002) Pathophysiology of pruritus in atopic dermatitis\u2014an overview. Exp Dermatol 11:12\u201324","DOI":"10.1034\/j.1600-0625.2002.110102.x"},{"key":"0521_CR25","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S, Luger T, Metze D (2001) Effective treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 44:471\u2013478","DOI":"10.1067\/mjd.2001.110059"},{"key":"0521_CR26","unstructured":"Tomi NS, Luger TA (in press) The treatment of atopic dermatitis with topical immunmodulators. Clin Dermatol"},{"key":"0521_CR27","doi-asserted-by":"crossref","unstructured":"Van Leent EJM, Gr\u00e4ber M, Thurston M et al. (1998) Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 134:805\u2013809","DOI":"10.1001\/archderm.134.7.805"},{"key":"0521_CR28","doi-asserted-by":"crossref","unstructured":"Wahn U, Bos JD, Goodfield M et al. (2002) Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatits in children. Pediatrics 110(1Pt1):e2","DOI":"10.1542\/peds.110.1.e2"},{"key":"0521_CR29","doi-asserted-by":"crossref","unstructured":"Zuberbier T, Chong SU, Grunow K et al. (2001) The ascomycin macrolactam pimecrolimus (Elidel\u00ae, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol 108:275\u2013280","DOI":"10.1067\/mai.2001.116865"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-003-0521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-003-0521-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-003-0521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-003-0521-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T22:20:31Z","timestamp":1601158831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-003-0521-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,21]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0521"],"URL":"https:\/\/doi.org\/10.1007\/s00105-003-0521-6","relation":{},"ISSN":["0017-8470"],"issn-type":[{"value":"0017-8470","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3,21]]}}}